Interleukin 37 (IL-37) Reduces High Glucose-Induced Inflammation, Oxidative Stress, and Apoptosis of Podocytes by Inhibiting the STAT3–Cyclophilin A (CypA) Signaling Pathway
- 21 July 2020
- journal article
- research article
- Published by International Scientific Information, Inc. in Medical Science Monitor
- Vol. 26, e922979-1-e922979-11
- https://doi.org/10.12659/msm.922979
Abstract
Background: Diabetic nephropathy (DN), the formation of albuminuria, is one of the most important complications seen in diabetic patients. IL-37, an inhibitor of congenital inflammation and immune response, plays an important role in the occurrence and development of diabetes, but its study in DN has not been previously reported. Material/Methods: Podocyte transfection techniques were used to overexpress STAT3 and cyclophilin A (CypA). The expression of IL-37, STAT3, and CypA was detected by RT-qPCR and western blot. Cell survival was detected by CCK-8. The expression of inflammatory factors and molecules related to oxidative stress was detected by ELISA and western blot, and cell apoptosis was detected by flow cytometry and western blot. Results: The expression of IL-37 was significantly decreased in high glucose-treated podocytes. IL-37 improved the sur- vival rate of podocytes suffering from high glucose-induced apoptosis. It inhibited the expression of the inflammation-related factors tumor necrosis factor alpha (TNF-alpha), IL-1 beta, IL-6, malondialdehyde (MDA), and lactate dehydrogenase (LDH), and promoted the expression of superoxide dismutase (SOD) in high glucose-treated podocytes. In addition, IL-37 inhibited the expression of the inflammation-related proteins MCP-1, NLRP3, ASC, and caspase-1. IL-37 also inhibited high glucose-induced apoptosis of podocytes by inhibiting the expression of the apoptosis-related proteins Bax and cleaved caspase-3/6/9, and by promoting the expression of Bcl-2. At the same time, we found that the STAT3/CypA signaling pathway was activated after induction by high glucose, while it was inhibited after treatment with IL-37. Overexpression of STAT3 and CypA inhibited the effects of IL-37 on the alleviation of inflammation and oxidative stress and on the reduction of apoptosis of high glucose-treated podocytes. Conclusions: IL-37 can significantly reduce podocyte inflammation, oxidative stress, and apoptosis induced by high glucose, and can inhibit the STAT3-CypA signaling pathway. Upregulation of the STAT3-CypA signaling pathway can inhibit the protective effect of IL-37 against podocyte injury induced by high glucose.This publication has 28 references indexed in Scilit:
- Urinary Cyclophilin A as a New Marker for Diabetic NephropathyMedicine, 2015
- The Novel Extracellular Cyclophilin A (CyPA) - Inhibitor MM284 Reduces Myocardial Inflammation and Remodeling in a Mouse Model of Troponin I -Induced MyocarditisPLOS ONE, 2015
- Research progress in signalling pathway in diabetic nephropathyDiabetes/Metabolism Research and Reviews, 2015
- IL-37 requires the receptors IL-18Rα and IL-1R8 (SIGIRR) to carry out its multifaceted anti-inflammatory program upon innate signal transductionNature Immunology, 2015
- Interleukin-37 ameliorates myocardial ischaemia/reperfusion injury in miceClinical and Experimental Immunology, 2014
- Elevated Plasma IL-37, IL-18, and IL-18BP Concentrations in Patients with Acute Coronary SyndromeMediators of Inflammation, 2014
- Swertiamarin attenuates inflammation mediators via modulating NF-κB/I κB and JAK2/STAT3 transcription factors in adjuvant induced arthritisEuropean Journal of Pharmaceutical Sciences, 2014
- Cyclophilin A is an inflammatory mediator that promotes atherosclerosis in apolipoprotein E–deficient miceThe Journal of Experimental Medicine, 2010
- Early Glomerular Filtration Defect and Severe Renal Disease in Podocin-Deficient MiceMolecular and Cellular Biology, 2004
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001